Browse by Day Archive

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

03/17/2026 7:45am
Pfizer said on Tuesday its experimental combination reduced the ​risk of disease progression or death by 40% in patients with breast cancer.